161 related articles for article (PubMed ID: 3557531)
1. [Multicenter evaluation of the activity and tolerance of a new antimycotic agent: ciclopiroxolamine].
Cattaneo M; Betti R; Lodi A; Masnada MC
G Ital Dermatol Venereol; 1986; 121(6):LXXXI-LXXXV. PubMed ID: 3557531
[No Abstract] [Full Text] [Related]
2. Topical treatment of dermatomycoses with Canesten cream, a new antimycotic compound.
el-Zawahry M; Moawad MK; Soliman M
Mykosen; 1973 Nov; 16(11):363-5. PubMed ID: 4771478
[No Abstract] [Full Text] [Related]
3. Clinical experience with Canesten-cream (Bay b 5097) against dermatophytes in Egypt.
Aal HA; Moawad MK
Mykosen; 1973 Nov; 16(11):369-71. PubMed ID: 4771479
[No Abstract] [Full Text] [Related]
4. [Ciclopiroxolamine in the treatment of pityriasis versicolor].
Trevisan G; Briscik E
G Ital Dermatol Venereol; 1988; 123(7-8):XXXIII-XXXV. PubMed ID: 3224994
[No Abstract] [Full Text] [Related]
5. [Clinical study with Hoe 296 in glabrous skin dermatophytosis and pityriasis versicolor].
González-Ochoa A; Sarmiento-Cristóbal J; Ortega-Llamas O
Rev Invest Salud Publica; 1974; 34(4):175-81. PubMed ID: 4617272
[No Abstract] [Full Text] [Related]
6. [Ketoconazole--a change in antimycotic therapy?].
Meinhof W
Hautarzt; 1983 Apr; 34(4):155-8. PubMed ID: 6303982
[No Abstract] [Full Text] [Related]
7. Topical agents in the treatment of superficial fungal infections.
Winfield JL
Int J Dermatol; 1978 Jun; 17(5):419-22. PubMed ID: 659044
[No Abstract] [Full Text] [Related]
8. [Superficial mycoses in immunosuppressed patients].
Hernanz Hermosa JM; Lázaro Ochaita P
Rev Clin Esp; 1995 Oct; 195 Suppl 3():49-55. PubMed ID: 9441306
[No Abstract] [Full Text] [Related]
9. [Our experience with antimycotic therapy with Tolnaftate].
Nunzi E; Carbone G
Minerva Dermatol; 1968 May; 43(5):230-2. PubMed ID: 5705341
[No Abstract] [Full Text] [Related]
10. [Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor].
Corte M; Jung K; Linker U; Martini H; Sapp-Boncelet I; Schulz H
Mycoses; 1989 Apr; 32(4):200-3. PubMed ID: 2755466
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy studies of haloprogin, a new topical antimicrobial agent.
Hermann HW
Arch Dermatol; 1972 Dec; 106(6):839-42. PubMed ID: 4565229
[No Abstract] [Full Text] [Related]
12. Comparison of oxiconazole (Ro 13-8996) and econazole in dermatomycoses.
Gip L
Mykosen; 1984 Jun; 27(6):295, 298-302. PubMed ID: 6382000
[No Abstract] [Full Text] [Related]
13. Bifonazole--a synopsis of clinical trials worldwide. Status and outlook.
Stettendorf S
Dermatologica; 1984; 169 Suppl 1():69-76. PubMed ID: 6241160
[TBL] [Abstract][Full Text] [Related]
14. Superficial mycoses: a strategic approach.
Rao A; Forgan-Smith R
Med J Aust; 1993 Apr; 158(7):476-7. PubMed ID: 8469198
[No Abstract] [Full Text] [Related]
15. New topical agents for dermatophytosis.
Smith EB
Cutis; 1976 Jan; 17(1):54-8. PubMed ID: 1037098
[TBL] [Abstract][Full Text] [Related]
16. [1% tioconazole powder in the treatment of dermatomycoses].
Tulli A; Leone E; De Simone C
Clin Ter; 1988 Sep; 126(6):417-20. PubMed ID: 2974403
[No Abstract] [Full Text] [Related]
17. Superficial mycoses: treatment with a new, broad-spectrum antifungal agent: 1% clotrimazole solution.
Zaias N; Battistini F
Arch Dermatol; 1977 Mar; 113(3):307-8. PubMed ID: 320940
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic evaluation of pyrrolnitrin in ointment on dermatophytes and tinea versicolor].
Macotela Ruíz E; López Martínez R; Lepe Santana G
Prensa Med Mex; 1974; 39(5-6):294-7. PubMed ID: 4474664
[No Abstract] [Full Text] [Related]
19. [Therapeutic experience in the use of a new antimycotic gel with phenylhydrargyri boras as an effective substance].
Pólay A; Szilágyi I
Mykosen; 1972 Mar; 15(3):111-7. PubMed ID: 4636061
[No Abstract] [Full Text] [Related]
20. [Treatment of dermatomycoses with Myco-Polycid].
Lukowska I
Mykosen; 1975 May; 18(5):245-8. PubMed ID: 1160933
[No Abstract] [Full Text] [Related]
[Next] [New Search]
